BORON-CONTAINING PROTEASOME INHIBITORS FOR USE AFTER PRIMARY CANCER THERAPY
- 专利权人:
- MILLENNIUM PHARMACEUTICALS. INC.
- 发明人:
- HUI, AI-MIN,LABOTKA, RICHARD,GUPTA, NEERAJ,VENKATAKRISHNAN, KARTHIK,LUI, GUOHUI
- 申请号：
- SG11201609259V
- 公开号：
- SG11201609259VA
- 申请日:
- 2015.05.19
- 申请国别(地区):
- SG
- 年份:
- 2016
- 代理人:
- 摘要：
- for treating cancer, or preventing cancer recurrence or progression； wherein ring A, Z1 and Z2 are as defined herein.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- CDC25A INHIBITOR FOR THE TREATMENT OF DRUG RESISTANT CANCER OR FOR THE PREVENTION OF TUMOR RELAPSE
- Proteasome inhibitors containing Boron to be used after Primary Therapy of cancer
- Combinations comprising mtor inhibitors for treating cancer
- Glutamate Dehydrogenase 1 Inhibitors and Methods of Treating Cancer
- Combination therapy using c-Met inhibitor and c-Myc inhibitor
